The project will be based at one of the country’s leading universities, Monash, and will produce 100 million doses of vaccine per year, against Covid-19, influenza and other diseases.
Article written by
Published
Reading time : 1 min.
The Moderna laboratory announced on Monday August 15 the opening of a messenger RNA vaccine factory in Melbourne, Australia, a first in the southern hemisphere. The project will be based at one of the country’s leading universities, Monash, and will produce 100 million doses of vaccine per year, against Covid-19, influenza and other diseases.
Moderna’s Spikevax against the coronavirus was among the first vaccines to use the new technology called messenger RNA developed during the Covid pandemic.
These vaccines, which can be developed quickly, use a molecule to teach the body to identify and fight a pathogen, such as Covid-19, unlike traditional vaccines, which contain a small piece of bacteria or virus. Construction of the Moderna factory is due to begin this year and be completed in 2024.